Incidence of Atypical Femoral Fractures in Patients on Osteoporosis Therapy—A Registry‐Based Cohort Study

ABSTRACT Atypical femoral fractures (AFFs) have been reported in patients taking bisphosphonates (BPs) for osteoporosis therapy but also in patients with no exposure to these drugs. In contrast, less is known about the incidence of AFFs in patients taking denosumab. This registry‐based cohort study...

وصف كامل

التفاصيل البيبلوغرافية
الحاوية / القاعدة:JBMR Plus
المؤلفون الرئيسيون: Judith Everts‐Graber, Harald Bonel, Daniel Lehmann, Brigitta Gahl, HansJörg Häuselmann, Ueli Studer, Hans‐Rudolf Ziswiler, Stephan Reichenbach, Thomas Lehmann
التنسيق: مقال
اللغة:الإنجليزية
منشور في: Oxford University Press 2022-10-01
الموضوعات:
AFF
ATYPICAL FEMORAL FRACTURES
BISPHOSPHONATES
DENOSUMAB
OSTEOPOROSIS
الوصول للمادة أونلاين:https://doi.org/10.1002/jbm4.10681

الانترنت

https://doi.org/10.1002/jbm4.10681

مواد مشابهة